UNSPSC 51401556: Tolufazepam

This classification denotes a benzodiazepine with the molecular formula C24H20Cl2N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98SR74X50D, chemically known as 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-1-(2-(p-tolylsulfonyl)ethyl)-2h-1,4-benzodiazepin-2-one but generally known as tolufazepam, which bears US NIH Compound Identifier 65647. European Medicines Agency schedules Tolufazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11182MIG.

UNSPSC 51401556 Tolufazepam, a Commodity code, shows a mismatch between its nominal classification and actual state and local procurement activity under it. The single recent opportunity posted to this code—Seminole County, Florida's IFB60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, products unrelated to the code's pharmaceutical name. State and local procurement bodies occasionally tag opportunities with codes that do not reflect the work actually being bought, and this appears to be such a case. Without additional opportunities supporting genuine activity under UNSPSC 51401556, the code shows little relevant recent state and local purchasing.

Seminole County issued the IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The contract carries a two-year initial term with a one-year renewal option, E-Verify compliance requirements, and standard insurance obligations including workers' compensation and commercial general liability. No explicit set-aside designations are noted, and FEMA funding introduces additional federal compliance requirements.